OSMT News and Press, Osmotica Pharmaceuticals plc From 05/13/21

First quarter 2021 total revenue of $23.9 million RVL Pharmaceuticals’ Upneeq wins 2021 MedTech Breakthrough Award; gains recognition as outstanding health and medical technology product Upneeq sales trend higher, exhibiting strong sequential growth St...

BRIDGEWATER, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, Chief Fi...

BRIDGEWATER, N.J., May 10, 2021 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals, Inc., a subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica”), a fully integrated biopharmaceutical company, today announced that its Upneeq ® (oxymetazoline hydroch...

BRIDGEWATER, N.J., May 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, today announced that the Company will release its 2021 first quarter financial results on ...

Galera Therapeutics (GRTX) +41% on updating data from pancreatic cancer trial.Willamette Valley Vineyards (WVVI) +18%.Nokia Corporation (NOK) +17% on Q1 results.VEREIT (VER) +17% as Realty Income to acquire the company.Enlivex Therapeutics (ENLV) +13%.Pluristem Therapeutics (PS...

Osmotica Pharmaceuticals plc (NASDAQ:OSMT) traded at a new 52-week low today of $3.01. So far today approximately 366,000 shares have been exchanged, as compared to an average 30-day volume of 331,000 shares. Osmotica Pharmaceuticals plc has overhead space with shares priced $3.03, or 7....

Osmotica closed its fourth quarter and full-year 2020 with dropping revenues. It looks as if another clinical trial will be required to refloat arbaclofen ER. Osmotica has signaled its interest in a strategic deal but has been reticent as to the form it might take. Upneeq is O...

Osmotica Pharmaceuticals plc (OSMT) Q4 2020 Results Conference Call March 30, 2021 4:30 PM ET Company Participants Lisa Wilson - Investor Relations Brian Markison - Chairman of the Board and Chief Executive Officer Andrew Einhorn - Chief Financial Officer James Schaub - Executive Vice Preside...

Gainers: [[ELOX]] +19.9%. [[SURF]] +15.0%. [[EVK]] +14.3%. [[EQ]] +10.4%. [[HYFM]] +9.2%.Losers: [[EDAP]] -7.4%. [[IMVT]] -5.3%. [[BYND]] -4.8%. [[CRMD]] -4.8%. [[OSMT]] -3.7%. For further details see: ELOX, SURF, EDAP and IMVT among after-hours movers

Osmotica Pharmaceuticals (OSMT): Q4 GAAP EPS of -$0.88 misses by $0.64.Revenue of $34.53M (-42.4% Y/Y) misses by $1.2M.Strengthened balance sheet by reducing $50 million in debt and increasing cash.Press Release For further details see: Osmotica Pharmaceuticals EPS misses by $0.64, miss...